SEMINARS IN IMMUNOLOGY

SEMINARS IN IMMUNOLOGY

SEMIN IMMUNOL
影响因子:7.8
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:ENGLAND
出版社:Academic Press Inc.
发刊时间:1989
发刊频率:Bimonthly
收录数据库:SCIE/Scopus收录
ISSN:1044-5323

期刊介绍

Seminars in Immunology is a review journal dedicated to keeping scientists informed of developments in the field of immunology on a topic by topic basis. Each issue is thematic in approach, devoted to an important topic of interest to immunologists, focusing on recent advances across a broad spectrum of research, from the molecular and cellular basis of the immune response to the possibilities for its manipulation. Every issue is edited by a guest editor, an internationally acknowledged expert in the field, and contains six to eight authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively review of a selected area, published rapidly to ensure currency.
《免疫学研讨会》是一份评论期刊,致力于让科学家了解免疫学领域的发展,以主题为基础。每一期都是主题性的,致力于免疫学家感兴趣的一个重要主题,集中在广泛研究领域的最新进展,从免疫应答的分子和细胞基础到其操作的可能性。每一期都由一位国际公认的该领域专家----客座编辑编辑编辑,并包含六至八篇关于该主题领域不同方面的权威特邀评论。每期的目的是提供一个协调,可读,生动的审查选定的领域,迅速出版,以确保货币。
年发文量 22
国人发稿量 1.96
国人发文占比 0.09%
自引率 -
平均录取率0
平均审稿周期 约稿?周期不定
版面费 US$3900
偏重研究方向 医学-免疫学
期刊官网 http://www.journals.elsevier.com/seminars-in-immunology/
投稿链接 https://www.editorialmanager.com/YSMIM

期刊高被引文献

Senescent cell clearance by the immune system: Emerging therapeutic opportunities.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.04.003
Global virus outbreaks: Interferons as 1st responders
来源期刊:Seminars in ImmunologyDOI:10.1016/j.smim.2019.101300
Immunologic mechanisms in asthma.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101333
Tim-3: A co-receptor with diverse roles in T cell exhaustion and tolerance.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101302
NK cells to cure cancer.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.03.004
Complement dysregulation in the central nervous system during development and disease.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101340
VISTA: a novel immunotherapy target for normalizing innate and adaptive immunity.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101308
Severe asthma phenotypes and endotypes.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101301
Targeting the adenosine pathway for cancer immunotherapy.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101304
Functions and regulation of T cell-derived interleukin-10.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101344
Innate lymphoid cells in intestinal cancer development.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.02.001
Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101305
Type III IFNs: Beyond antiviral protection.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101303
Immune induction of airway remodeling.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101346
Regulation of regulators: Role of the complement factor H-related proteins.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101341
IL-10-producing regulatory B cells and plasmocytes: Molecular mechanisms and disease relevance.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101323
The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1)1.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101338
Innate lymphoid cells as regulators of the tumor microenvironment.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.03.002
Il-10 producing T and B cells in allergy.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101326
Common gamma chain cytokines and CD8 T cells in cancer.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101307
Type I interferon signaling, regulation and gene stimulation in chronic virus infection.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.05.001
Immune regulation and cytotoxic T cell activation of IL-10 agonists – Preclinical and clinical experience
来源期刊:Seminars in ImmunologyDOI:10.1016/j.smim.2019.101325
Helper-like innate lymphoid cells and cancer immunotherapy.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.04.002
Hide and seek: Plasticity of innate lymphoid cells in cancer.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.04.001
CEACAM1 structure and function in immunity and its therapeutic implications.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101296
IFN-γ: A cytokine at the right time, is in the right place.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.05.002
Regulation of the complement system and immunological tolerance in pregnancy.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101337
Innate lymphoid cells: A potential link between microbiota and immune responses against cancer.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.03.003
ILC regulation of T cell responses in inflammatory diseases and cancer.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101284
Epigenetic and transcriptional mechanisms for the regulation of IL-10.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101324
Cellular therapy approaches harnessing the power of the immune system for personalized cancer treatment.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101306
Glycogen synthase 3 (GSK-3) regulation of PD-1 expression and and its therapeutic implications.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101295
CTLA-4 (CD152): A versatile receptor for immune-based therapy.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101298
Complement dysregulation in glomerulonephritis.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101331
The pro- and anti-tumor role of ILC2s.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.04.004
Too much of a good thing: Detrimental effects of interferon.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101282
Asthma from immune pathogenesis to precision medicine.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101294
Complement activation and regulation in rheumatic disease.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101339
Title: IL-10-producing T cells and their dual functions.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101335
Tissue-resident cytotoxic innate lymphoid cells in tumor immunosurveillance.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.03.001
ILCs in hematologic malignancies: Tumor cell killers and tissue healers.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.06.002
IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101330
Interleukin-10 mediated immune regulation after stem cell transplantation: Mechanisms and implications for therapeutic intervention.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101322
Innate lymphoid cells and cancer at border surfaces with the environment.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.06.001
PROPERTIES AND FUNCTIONS OF THE NOVEL TYPE I INTERFERON EPSILON.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101328
Immunological biomarkers in severe asthma.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101332
来源期刊:DOI:
Allergen immunotherapy (AIT) in asthma.
来源期刊:Seminars in immunologyDOI:10.1016/j.smim.2019.101334

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
0.00%33.77%--

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
IMMUNOLOGY
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学2区
IMMUNOLOGY 免疫学
2区
2023年12月升级版
医学2区
IMMUNOLOGY 免疫学
2区
2022年12月旧的升级版
医学2区
IMMUNOLOGY 免疫学
2区